Print

Biodesix, Inc. and Capital Royalty Close Financing Transaction  
1/10/2014 9:54:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced that the company closed a structured debt financing with Capital Royalty Partners L.P. The transaction provides Biodesix® with up to $20 million of capital.

Help employers find you! Check out all the jobs and post your resume.

//-->